FDA approves Tzield for children with new stage 3 type 1 diabetes

Medical Xpress

FDA approves Tzield for children with new stage 3 type 1 diabetes

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

The U.S.

Food and Drug Administration has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) to delay the decline in endogenous insulin production in children aged 8 to 17 years recently diagnosed with stage 3 type 1 diabetes. ...

전문 보기

FDA approves Tzield for children with new stage 3 type 1 diabetes

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

More Canadian than the beaver? Scientists discover a western toad found only in Canada

Migration is dropping, but public concern is climbing. Why?

Ecological factors, not social behavior, explain brain size in cephalopods

Medical Xpress의 다른 기사

Dual-mobility hip replacement implant can lower dislocation risk by 70%

Virus influences rare brain lymphomas, large study finds

Bofanglutide linked to meaningful reductions in HbA1c in adults with T2DM